Skip to main content

Production and Use of Positron-Emitting Test Substances for Tumor Diagnosis

  • Conference paper
Nuclear Medicine in Clinical Oncology

Abstract

New therapeutic regimes like combinations of radio- or chemotherapy with hyperthermia have given rise to growing interest in methods for the in vivo assessment of tumor physiology and metabolism [1]. These methods usually require the use of radioactive compounds which undergo well-defined processes in the organism. Therefore, the attempt to monitor biologic properties of tumors necessitates considering organic radiopharmaceuticals and, in particular, positron emitters. This paper deals with the application of organic radioagents for the assessment of microcirculation and cellular integrity in tumors, and for therapeutic research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Reimann RE, Rosen G, Gelbard AS, Benua RS, Yeh SDJ, Laughlin JS (1985) Diagnostic demands in clinical and experimental oncology: application of substrates labeled with positron-emitting radionuclides. In: Knapp WH, Vyska K (eds) Tumor cell physiology and positron emission tomography. Springer, Berlin Heidelberg New York Tokyo, pp 73–85

    Google Scholar 

  2. Knapp WH, Helus F, Oberdorfer F, Layer K, Sinn HJ, Ostertag H, Matzku S (1985) 11 C-butanol for imaging of the blood-flow distribution in tumor-bearing animals. Eur J Nucl Med 10:540–548

    Article  PubMed  CAS  Google Scholar 

  3. Oberdorfer F, Helus F, Maier-Borst W et al (1982) The synthesis of (l-11C)-butanol. Radiochem Radioanal Lett 53:237–252

    CAS  Google Scholar 

  4. Knapp WH, Helus F, Sinn H, Ostertag H, Georgí P, Brandeis W-E, Braun A (1984) 13N-L-glutamate uptake in malignancy: its relationship to blood flow. J Nucl Med 25:989–997

    PubMed  CAS  Google Scholar 

  5. Knapp WH, Debatin J, Layer K, Helus F, Altmann A, Sinn HJ, Ostertag H (1985) Selective drug-induced reduction of blood flow in tumor transplants. Int J Radiat Oncol Biol Phys 11:1357–1366

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Knapp, W.H. (1986). Production and Use of Positron-Emitting Test Substances for Tumor Diagnosis. In: Winkler, C. (eds) Nuclear Medicine in Clinical Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70947-0_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70947-0_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-16164-6

  • Online ISBN: 978-3-642-70947-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics